Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Decreased by Pinnacle Wealth Management LLC

Pinnacle Wealth Management LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,580 shares of the medical equipment provider’s stock after selling 56 shares during the quarter. Intuitive Surgical accounts for about 3.2% of Pinnacle Wealth Management LLC’s portfolio, making the stock its 10th largest position. Pinnacle Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,913,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the stock. Atala Financial Inc purchased a new position in Intuitive Surgical in the fourth quarter valued at $25,000. Hurley Capital LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at $28,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at $26,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at $26,000. Finally, BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. Truist Financial dropped their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a report on Wednesday, April 23rd. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Finally, UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $596.05.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 2,401 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares of the company’s stock, valued at $4,060,424.28. This represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,700 shares of company stock worth $16,865,621. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $542.67 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The company has a market capitalization of $194.50 billion, a price-to-earnings ratio of 84.66, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The firm has a 50-day simple moving average of $510.44 and a 200-day simple moving average of $537.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.